在心肌梗塞后,TRIM44通过TAK1稳定加剧心脏纤维化
Hao Qian1, Zhengri Lu1, Chunshu Hao1
1Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Cellular signalling
|June 4, 2023
概括
通过稳定TAK1.1,TRIM44促进心肌梗塞后的心脏纤维化. 抑制TRIM44在小鼠模型中减少了纤维化,表明TRIM44是心脏病的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 纤维化研究 纤维化研究
背景情况:
- 心肌梗塞 (MI) 导致心脏纤维化,这种情况没有有效的治疗方法.
- 众所周知,TRIM44是一种E3结合酶,可促进瘤细胞的生长和迁移.
- 在心脏纤维化中TRIM44的作用仍然未被探索.
研究的目的:
- 研究TRIM44在心脏纤维化中的作用.
- 阐明TRIM44在纤维化中的作用的潜在分子机制.
- 评估TRIM44作为心脏纤维化的潜在治疗标.
主要方法:
- 已建立的小鼠模型的心肌梗塞 (MI) 和TGF-β1诱导的心脏纤维化.
- 在体内和体外 (心脏纤维细胞) 使用了TRIM44的淘汰和过度表达.
- 研究了涉及TAK1稳定性,无处不在和MAPK信号传递的机制.
主要成果:
- 在心脏病发作模型中,TRIM44 knockdown 显著抑制了心脏纤维化.
- 在心脏纤维细胞和MI模型中,TRIM44过度表达增强了纤维化标志物.
- TRIM44通过抑制多基化,激活MAPK和促进纤维化来稳定TAK1.
结论:
- TRIM44在促进心脏纤维化方面发挥着至关重要的作用.
- TRIM44通过稳定TAK1而起作用,从而导致MAPK的激活.
- TRIM44代表了治疗心脏纤维化的有前途的治疗标.
更多相关视频
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.3K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.5K
相关概念视频
Myocarditis I: Introduction
10
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
10
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
470
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
470
